Quinapril hydrochloride - Generic Drug Details

What are the generic sources for quinapril hydrochloride and what is the scope of patent protection?

Quinapril hydrochloride is the generic ingredient in two branded drugs marketed by Pfizer Pharms, Actavis Elizabeth, Actavis Labs Fl Inc, Ani Pharms, Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Invagen Pharms, Lupin, Mylan, Norvium Bioscience, Prinston Inc, and Sun Pharm Inds Ltd, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for quinapril hydrochloride. Ten suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for quinapril hydrochloride

US Patents:	0
Tradenames:	2
Applicants:	13
NDAs:	14
Drug Master File Entries:	10
Finished Product Suppliers / Packagers:	10
Raw Ingredient (Bulk) Api Vendors:	85
Clinical Trials:	27
Patent Applications:	4,926
What excipients (inactive ingredients) are in quinapril hydrochloride?	quinapril hydrochloride excipients list
DailyMed Link:	quinapril hydrochloride at DailyMed

Recent Clinical Trials for quinapril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
AHEPA University Hospital	Phase 4
University of Nebraska	Phase 4
Pfizer

See all quinapril hydrochloride clinical trials

Generic filers with tentative approvals for QUINAPRIL HYDROCHLORIDE

Applicant	Application No.	Strength	Dosage Form
		EQ 40MG BASE	TABLET;ORAL
		EQ 20MG BASE	TABLET;ORAL
		EQ 10MG BASE	TABLET;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Pharmacology for quinapril hydrochloride

Drug Class	Angiotensin Converting Enzyme Inhibitor
Mechanism of Action	Angiotensin-converting Enzyme Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for quinapril hydrochloride

C09AA	ACE inhibitors, plain
C09A	ACE INHIBITORS, PLAIN
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C	Cardiovascular system

US Patents and Regulatory Information for quinapril hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Labs Fl Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076049-002	Jan 14, 2005		DISCN	No	No
Norvium Bioscience	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076694-003	Dec 23, 2004		DISCN	No	No
Norvium Bioscience	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076694-002	Dec 23, 2004		DISCN	No	No
Sun Pharm Inds Ltd	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	090800-003	Jun 18, 2009		DISCN	No	No
Actavis Labs Fl Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076049-001	Jan 14, 2005		DISCN	No	No
Prinston Inc	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	205823-004	Sep 15, 2016	AB	RX	No	No

Expired US Patents for quinapril hydrochloride

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-004	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-004	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-003	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-001	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-001	Nov 19, 1991
Pfizer Pharms	ACCUPRIL	quinapril hydrochloride	TABLET;ORAL	019885-002	Nov 19, 1991